We are live on ! Find out more
IRON icon

Disc Medicine

62 hedge funds and large institutions have $93.8M invested in Disc Medicine in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 18 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

246% more call options, than puts

Call options by funds: $211K | Put options by funds: $61K

15.38% more ownership

Funds ownership: 59.39% → 74.77% (+15%)

0% more funds holding

Funds holding: 62 → 62 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

17% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 18

31% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 13

68% less capital inflows, than outflows

Capital inflows: $1.96M | Capital outflows: $6.13M

Holders
62
Holders Change
–
Holders Change %
0%
% of All Funds
0.95%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
15
Reduced
18
Closed
13
Calls
$211​K
Puts
$61​K
Net Calls
+$150​K
Net Calls Change
-⁠$1.46​M

IRON Hedge Fund Activity: Q4 2021 in Review

62 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Disc Medicine (IRON) for Q4 2021, worth a combined $93.8M — down 9.4% from $103M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of IRON and 9 opened new positions — a net loss of 4 holders — while 18 trimmed existing stakes and 15 added.

The largest buyer was Suvretta Capital Management, adding an estimated $766K. The largest seller was Vanguard Group, cutting an estimated $1.55M.

  • 62 institutional investors held Disc Medicine (IRON) as of Q4 2021, unchanged from Q3 2021.
  • Funds reported $93.8M of Disc Medicine stock for Q4 2021, down 9.4% quarter-over-quarter.
  • 9 funds opened new Disc Medicine positions in Q4 2021 and 13 closed out, a net change of -4 holders.
  • The largest Disc Medicine buyer in Q4 2021 was Suvretta Capital Management, an estimated $766K added.
  • The largest Disc Medicine seller in Q4 2021 was Vanguard Group, an estimated $1.55M sold.

Based on aggregated 13F filings for Q4 2021.